# DIFFERIN
> **NDA022502** · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2010-03-17
## Drug
- **FDA Application Number:** NDA022502
- **Application type:** New Drug Application
- **Brand name:** DIFFERIN
- **Generic name:** Adapalene
- **Active ingredients:** ADAPALENE
- **Dosage form:** LOTION
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** GALDERMA LABS LP
- **First approval:** 2010-03-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022502)
---
*AI Analytics · CC0 1.0*